Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 3
2005 1
2006 1
2007 1
2008 1
2011 1
2012 1
2013 1
2014 1
2015 1
2017 1
2018 2
2020 2
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study.
Juul MB, Jelicic J, Anru PL, Engberg H, Hammershøj Jensen P, Kristensen HB, Baech J, Clausen MR, Gang AO, Munksgaard L, El-Galaly TC, Frederiksen H, Stauffer Larsen T. Juul MB, et al. Among authors: munksgaard l. Leuk Lymphoma. 2022 Sep;63(9):2074-2083. doi: 10.1080/10428194.2022.2064982. Epub 2022 Apr 18. Leuk Lymphoma. 2022. PMID: 35437098
[Infectious causes of non-Hodgkin lymphomas].
Munksgaard L, Hjalgrim H, Melbye M. Munksgaard L, et al. Ugeskr Laeger. 2002 Dec 9;164(50):5927-32. Ugeskr Laeger. 2002. PMID: 12553112 Review. Danish.
[Epstein-Barr virus and Hodgkin's lymphoma].
Hjalgrim H, Munksgaard L, Melbye M. Hjalgrim H, et al. Among authors: munksgaard l. Ugeskr Laeger. 2002 Dec 9;164(50):5924-7. Ugeskr Laeger. 2002. PMID: 12553111 Review. Danish.
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis.
Leppä S, Jørgensen J, Tierens A, Meriranta L, Østlie I, de Nully Brown P, Fagerli UM, Larsen TS, Mannisto S, Munksgaard L, Maisenhölder M, Vasala K, Meyer P, Jerkeman M, Björkholm M, Fluge Ø, Jyrkkiö S, Liestøl K, Ralfkiaer E, Spetalen S, Beiske K, Karjalainen-Lindsberg ML, Holte H. Leppä S, et al. Among authors: munksgaard l. Blood Adv. 2020 May 12;4(9):1906-1915. doi: 10.1182/bloodadvances.2020001518. Blood Adv. 2020. PMID: 32380536 Free PMC article. Clinical Trial.
Borrelia infection and risk of non-Hodgkin lymphoma.
Schöllkopf C, Melbye M, Munksgaard L, Smedby KE, Rostgaard K, Glimelius B, Chang ET, Roos G, Hansen M, Adami HO, Hjalgrim H. Schöllkopf C, et al. Among authors: munksgaard l. Blood. 2008 Jun 15;111(12):5524-9. doi: 10.1182/blood-2007-08-109611. Epub 2008 Apr 18. Blood. 2008. PMID: 18424667 Free PMC article.
Atopy and risk of non-Hodgkin lymphoma.
Melbye M, Smedby KE, Lehtinen T, Rostgaard K, Glimelius B, Munksgaard L, Schöllkopf C, Sundström C, Chang ET, Koskela P, Adami HO, Hjalgrim H. Melbye M, et al. Among authors: munksgaard l. J Natl Cancer Inst. 2007 Jan 17;99(2):158-66. doi: 10.1093/jnci/djk019. J Natl Cancer Inst. 2007. PMID: 17227999
The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.
Ahmad SM, Martinenaite E, Holmström M, Jørgensen MA, Met Ö, Nastasi C, Klausen U, Donia M, Pedersen LM, Munksgaard L, Ødum N, Woetmann A, Svane IM, Andersen MH. Ahmad SM, et al. Among authors: munksgaard l. Oncoimmunology. 2017 Nov 1;7(2):e1390641. doi: 10.1080/2162402X.2017.1390641. eCollection 2018. Oncoimmunology. 2017. PMID: 29308318 Free PMC article.
20 results